Canada Announces New Infusion Pump Performance Standards
Executive Summary
Canadian authorities are requiring new performance data to demonstrate the accuracy of some infusion pumps.
You may also be interested in...
Final Guidance: Assurance Cases, But Not Always Clinicals, For Infusion Pumps
In response to a growing number of adverse events, FDA has asked infusion pump manufacturers to submit safety assurance cases to help understand the safety profile of their device when submitting a 510(K). But a final guidance appears to soften expectations that clinical studies always be performed to support clearance.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.